At Epinoma, we harness our protein engineering platform to build epigenetic-driven diagnostics and therapeutics.
Epigenetics refers to changes in gene expression that occur through various chemical alterations, including the addition of methyl groups on DNA, changes in chromatin accessibility, and modifications to the chromosomal packaging in our cells.
Epigenetic marks add a new dimension of biological data and provide key insights about gene expression. Improving the underlying tools to study and analyze epigenetics will allow us to fundamentally drive new paradigms for both disease detection and disease treatment.